CHA this week attended a stakeholder meeting held by the Food and Drug Administration (FDA) on the root cause of drug shortages. Ahead of the meeting, CHA submitted a comment letter that identifies underlying systemic causes and makes recommendations to prevent or mitigate drug shortages.
This content is restricted to members.
